학술논문
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Document Type
Article
Author
Corrie, Pippa G; Marshall, Andrea; Dunn, Janet A; Middleton, Mark R; Nathan, Paul D; Gore, Martin; Davidson, Neville; Nicholson, Steve; Kelly, Charles G; Marples, Maria; Danson, Sarah J; Marshall, Ernest; Houston, Stephen J; Board, Ruth E; Waterston, Ashita M; Nobes, Jenny P; Harries, Mark; Kumar, Satish; Young, Gemma; Lorigan, Paul
Source
In The Lancet Oncology May 2014 15(6):620-630
Subject
Language
ISSN
1470-2045